Resources for You
Zenpep (Pancrelipase) Delayed-release Capsules
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2013
- Postmarketing data for Zenpep have been available since 2009. The following adverse reactions have been identified during post-approval use of Zenpep…
PATIENT COUNSELING INFORMATION
Dosing and Administration
- Instruct patients and caregivers to notify the healthcare professional if the patient has a history of abnormal glucose levels before initiating treatment with Zenpep.
- Pregnancy and Breast Feeding - Instruct patients to notify their healthcare professional if they are pregnant or thinking of becoming pregnant during treatment with Zenpep…